| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: disclosed compounds act specifically through antagonistic inhibition of the LHRH receptor. The invention also relates to medicinal agents containing at least one novel compound as an active component. The medicinal agents are suitable particularly for use as measured peroral drug formulations for mammals, particularly humans. ^ EFFECT: novel tetrahydrocarbazole derivatives have improved properties and can be used as GPCR receptor inhibitors. ^ 23 cl, 11 dwg, 9 tbl, 15 ex |
